Editas Medicine, Inc. (EDIT)
NASDAQ: EDIT · Real-Time Price · USD
2.620
-0.060 (-2.24%)
At close: Jul 28, 2026, 4:00 PM EDT
2.590
-0.030 (-1.15%)
After-hours: Jul 28, 2026, 7:56 PM EDT

Editas Medicine Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
38.6940.5232.3178.1219.7125.54
Revenue Growth
7.97%25.39%-58.64%296.32%-22.83%-71.85%
Gross Profit
38.6940.5232.3178.1219.7125.54
Operating Income
-108.85-160.01-251.15-169.18-225.95-193.15
Net Income
-108.95-160.06-237.09-153.22-220.43-192.5
Earnings Per Share
-1.23-1.80-2.88-2.02-3.21-2.85
EPS Growth
------

Cash & Debt

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
123.65146.65269.91323.11344.27499.85
Total Debt
71.9776.7192.4736.5443.9526.38
Net Cash (Debt)
51.6769.94177.45286.58300.33473.47
Net Cash Growth
-61.79%-60.59%-38.08%-4.58%-36.57%25.93%
Net Cash Per Share
0.560.792.163.774.377.00

Cash Flow & CapEx

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-140.5-165.24-210.28-132.18-177.35-163.8
Capital Expenditures
-0.59-0.61-8.83-4.72-4.12-7.98
Free Cash Flow
-141.09-165.85-219.11-136.9-181.47-171.78
Free Cash Flow Growth
------

Margins

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
100.00%100.00%100.00%100.00%100.00%100.00%
Operating Margin
-281.32%-394.89%-777.22%-216.56%-1146.26%-756.13%
Pretax Margin
-281.59%-395.01%-733.72%-196.13%-1118.26%-753.61%
Profit Margin
-281.59%-395.01%-733.72%-196.13%-1118.26%-753.61%
FCF Margin
-364.63%-409.30%-678.06%-175.23%-920.59%-672.49%

Valuation

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
10.394.953.2510.6030.9871.13